AUGMENTED CONDITIONING WITH TARGETED MOLECULAR RADIOTHERAPY PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN MYELOMA: RESULTS OF A PHASE II RANDOMISED CONTROL TRIAL WITH IMPROVED CR RATE POST ASCT